Surmodics, Inc.

NasdaqGS:SRDX 株式レポート

時価総額：US$598.4m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Surmodics マネジメント

マネジメント 基準チェック /34

Surmodics'の CEO はGary Maharajで、 Dec2010年に任命され、 の在任期間は 13.5年です。 の年間総報酬は$ 3.53Mで、 18.2%給与と81.8%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の1.34%を直接所有しており、その価値は$ 8.04M 。経営陣と取締役会の平均在任期間はそれぞれ6.1年と13.5年です。

主要情報

Gary Maharaj

最高経営責任者

US$3.5m

報酬総額

CEO給与比率18.2%
CEO在任期間13.5yrs
CEOの所有権1.3%
経営陣の平均在職期間6.1yrs
取締役会の平均在任期間13.5yrs

経営陣の近況

Shareholders May Be Wary Of Increasing Surmodics, Inc.'s (NASDAQ:SRDX) CEO Compensation Package

Feb 03
Shareholders May Be Wary Of Increasing Surmodics, Inc.'s (NASDAQ:SRDX) CEO Compensation Package

Recent updates

There's Reason For Concern Over Surmodics, Inc.'s (NASDAQ:SRDX) Massive 29% Price Jump

Jun 06
There's Reason For Concern Over Surmodics, Inc.'s (NASDAQ:SRDX) Massive 29% Price Jump

Is Now The Time To Look At Buying Surmodics, Inc. (NASDAQ:SRDX)?

May 30
Is Now The Time To Look At Buying Surmodics, Inc. (NASDAQ:SRDX)?

Surmodics (NASDAQ:SRDX) Is Experiencing Growth In Returns On Capital

May 02
Surmodics (NASDAQ:SRDX) Is Experiencing Growth In Returns On Capital

We Think Surmodics (NASDAQ:SRDX) Can Stay On Top Of Its Debt

Sep 17
We Think Surmodics (NASDAQ:SRDX) Can Stay On Top Of Its Debt

News Flash: Analysts Just Made A Notable Upgrade To Their Surmodics, Inc. (NASDAQ:SRDX) Forecasts

Jun 26
News Flash: Analysts Just Made A Notable Upgrade To Their Surmodics, Inc. (NASDAQ:SRDX) Forecasts

An Intrinsic Calculation For Surmodics, Inc. (NASDAQ:SRDX) Suggests It's 27% Undervalued

Jun 22
An Intrinsic Calculation For Surmodics, Inc. (NASDAQ:SRDX) Suggests It's 27% Undervalued

Is Surmodics (NASDAQ:SRDX) A Risky Investment?

May 14
Is Surmodics (NASDAQ:SRDX) A Risky Investment?

Market Participants Recognise Surmodics, Inc.'s (NASDAQ:SRDX) Revenues Pushing Shares 36% Higher

Apr 17
Market Participants Recognise Surmodics, Inc.'s (NASDAQ:SRDX) Revenues Pushing Shares 36% Higher

Shareholders May Be Wary Of Increasing Surmodics, Inc.'s (NASDAQ:SRDX) CEO Compensation Package

Feb 03
Shareholders May Be Wary Of Increasing Surmodics, Inc.'s (NASDAQ:SRDX) CEO Compensation Package

Surmodics (NASDAQ:SRDX) Has Debt But No Earnings; Should You Worry?

Jan 08
Surmodics (NASDAQ:SRDX) Has Debt But No Earnings; Should You Worry?

Surmodics gets additional $125M in credit facility

Oct 17

Surmodics Non-GAAP EPS of -$0.34 beats by $0.04, revenue of $24.9M misses by $0.29M

Jul 27

Estimating The Intrinsic Value Of Surmodics, Inc. (NASDAQ:SRDX)

Jul 22
Estimating The Intrinsic Value Of Surmodics, Inc. (NASDAQ:SRDX)

Is It Too Late To Consider Buying Surmodics, Inc. (NASDAQ:SRDX)?

May 03
Is It Too Late To Consider Buying Surmodics, Inc. (NASDAQ:SRDX)?

Shareholders May Not Be So Generous With Surmodics, Inc.'s (NASDAQ:SRDX) CEO Compensation And Here's Why

Feb 04
Shareholders May Not Be So Generous With Surmodics, Inc.'s (NASDAQ:SRDX) CEO Compensation And Here's Why

Do Surmodics's (NASDAQ:SRDX) Earnings Warrant Your Attention?

Dec 24
Do Surmodics's (NASDAQ:SRDX) Earnings Warrant Your Attention?

Estimating The Fair Value Of Surmodics, Inc. (NASDAQ:SRDX)

Aug 13
Estimating The Fair Value Of Surmodics, Inc. (NASDAQ:SRDX)

When Should You Buy Surmodics, Inc. (NASDAQ:SRDX)?

Jun 09
When Should You Buy Surmodics, Inc. (NASDAQ:SRDX)?

CEO報酬分析

Surmodics の収益と比較して、Gary Maharaj の報酬はどのように変化したか？
日付総報酬給与会社業績
Mar 31 2024n/an/a

US$14m

Dec 31 2023n/an/a

US$6m

Sep 30 2023US$4mUS$640k

-US$2m

Jun 30 2023n/an/a

-US$23m

Mar 31 2023n/an/a

-US$36m

Dec 31 2022n/an/a

-US$32m

Sep 30 2022US$3mUS$620k

-US$27m

Jun 30 2022n/an/a

-US$13m

Mar 31 2022n/an/a

-US$10m

Dec 31 2021n/an/a

US$2m

Sep 30 2021US$3mUS$602k

US$4m

Jun 30 2021n/an/a

US$2m

Mar 31 2021n/an/a

US$7m

Dec 31 2020n/an/a

US$701k

Sep 30 2020US$3mUS$585k

US$1m

Jun 30 2020n/an/a

US$8m

Mar 31 2020n/an/a

US$7m

Dec 31 2019n/an/a

US$6m

Sep 30 2019US$2mUS$568k

US$8m

Jun 30 2019n/an/a

US$2m

Mar 31 2019n/an/a

-US$2m

Dec 31 2018n/an/a

-US$2m

Sep 30 2018US$2mUS$551k

-US$4m

Jun 30 2018n/an/a

-US$2m

Mar 31 2018n/an/a

US$1m

Dec 31 2017n/an/a

US$70k

Sep 30 2017US$2mUS$526k

US$4m

報酬と市場: Garyの 総報酬 ($USD 3.53M ) は、 US市場 ($USD 2.44M ) の同規模の企業の平均を上回っています。

報酬と収益: Garyの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Gary Maharaj (61 yo)

13.5yrs

在職期間

US$3,527,263

報酬

Mr. Gary R. Maharaj has been the Chief Executive Officer and President at Surmodics, Inc. since December 27, 2010. Mr. Maharaj served as the Chief Executive Officer and President at Arizant Inc. from 2006...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Gary Maharaj
CEO, President & Director13.5yrsUS$3.53m1.34%
$ 8.0m
Timothy Arens
Senior VP of Finance & Information Technology and CFO6.1yrsUS$1.30m0.53%
$ 3.2m
Gordon Weber
Senior VP of Legal4.1yrsUS$1.10m0.15%
$ 925.9k
Charles Olson
Senior VP & President of Medical Device Coatings19.7yrsUS$1.12m0.37%
$ 2.2m
Teryl L. Sides
Senior VP & President of Vascular Interventions2.1yrsUS$1.49m0.25%
$ 1.5m
John Manders
Corporate Controller6.1yrsデータなし0.058%
$ 349.1k
Joseph Stich
Senior VP of Human Resources & President of In Vitro Diagnostics4.2yrsUS$970.92k0.43%
$ 2.6m

6.1yrs

平均在職期間

59yo

平均年齢

経験豊富な経営陣: SRDXの経営陣は経験豊富で経験豊富です（平均在職期間は6.1年）。

取締役

名称ポジション在職期間報酬所有権
Gary Maharaj
CEO, President & Director13.5yrsUS$3.53m1.34%
$ 8.0m
Ronald Kalich
Independent Director10.3yrsUS$186.50k0.066%
$ 396.0k
David Dantzker
Independent Director13.4yrsUS$185.00k0.056%
$ 333.0k
Susan Knight
Independent Non-Executive Chair of the Board16.4yrsUS$229.00k0.13%
$ 749.5k
José Bedoya
Independent Director22.4yrsUS$176.50k0.033%
$ 199.5k
Lisa Heine
Independent Director7.2yrsUS$176.50k0.023%
$ 140.6k

13.5yrs

平均在職期間

69yo

平均年齢

経験豊富なボード: SRDXの 取締役会 は経験豊富で 経験豊富 です ( 13.5年の平均在任期間)。